FDA Approved: JELMYTO — Supplemental Application (UroGen Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for JELMYTO (mitomycin) by UroGen Pharma, Inc. The approval updates the product labeling and/or indication for use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• JELMYTO (MITOMYCIN)

Snippet

SUPPL AP for JELMYTO (MITOMYCIN)